Table I.
Genes | Sequences |
---|---|
miR-93 | F: 5′-GAAGATCTACCTTCACTGAGAGGGTGGT-3′ |
R: 5′-CGGAATTCACCAGACCCTTTTGAACGCC-3′ | |
U6 | F: 5′-CTCGCTTCGGCAGCACA-3′ |
R: 5′-AACGCTTCACGAATTTGCGT-3′ | |
DAB2 | F: 5′-TGGACGATGTGCTCTATGCC-3′ |
R: 5′-GGATGGTGATGGTTTGGTAG-3′ | |
TGFBR2 | F: 5′-CCTGAGAGGAGAT GAAGTAG-3′ |
R: 5′-CTTAAAGTATAAGAGCCTGCA-3′ | |
ITGB8 | F: 5′-CGTGACTTTCGTCTTGGATTTGG-3′ |
R: 5′-TCCTTTCGGGGTGGATGCTAA-3′ | |
CDKN1A | F: 5′-CGATGGAACTTCGACTTTGTCA-3′ |
R: 5′-GCACAAGGGTACAAGACAGTG-3′ | |
BTG3 | F: 5-ATGAAGAATGAAATTGCTGCCGTTG-3′ |
R: 5′-GTGAGGTGCTAACATGTGAGGATT-3′ | |
β-actin | F: 5-TGAGCGCGGCTACAGCTT-3′ |
R: 5′-TCCTTAATGTCACGCACGATTT-3′ |
RT-qPCR, reverse transcription-quantitative polymerase chain reaction; miR-93, microRNA-93; DAB2, disabled 2; TGFBR2, transforming growth factor beta receptor II; ITGB8, Integrin beta8; CDKN1A, cyclin-dependent kinase (CDK) inhibitor p21; BTG3, B-cell translocation gene 3; F, forward; R, reverse.